THE HEMOPHAGOCYTIC SYNDROME: Titrating Continuous Hemofiltration to the Degree of Lactic Acidosis

REFERENCES

• Lim M E, Kim K S. Hemophagocytic lymphohistiocytosis. Pediatr Infect Dis J 1999; 18: 154–155, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Imashuku S, Hlbi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997; 130: 352–357, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Henter J I, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18: 29–33, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Arico M, Janka G, Fischer A. Hemophagocytic lymphohistiocytosis: report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996; 10: 197–203, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Grom A A. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003; 15: 587–590, [CSA]
   Google Scholar
• Dhote R, Simon J, Papo T. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003; 49: 633–639, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sullivan K E, Delaat C A, Douglas S D, Filipovich A H. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res 1998; 44: 465–468, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Egeler R M, Shapiro R, Loechelt B, Filipovich A. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 1996; 18: 340–345, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Henter J I, Samuelsson-Horne A, Arico M. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367–2373, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Levendoglu-Tugal O, Ozkaynak M F, LaGamma E, Sherbany A, Sandoval C, Jayabose S. Hemophagocytic lymphohistiocytosis presenting with thrombocytopenia in the newborn. J Pediatr Hematol Oncol 2002; 24: 405–409, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Takahashi T, Abe T, Sato T. Elevated sphingomyelinase and hypercytokinemia in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 2002; 24: 401–404, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Osugi Y, Hara J, Tagawa S. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997; 89: 4100–4103, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Henter J I, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918–2922, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• DiCarlo J V, Alexander S R, Agarwal R, Schiffman J D. Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol 2003; 25: 801–805, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• DiCarlo J V, Dudley T E, Sherbotie J R, Kaplan B S, Costarino A T. Continuous arteriovenous hemofiltrationdi alysis improves pulmonary gas exchange in children with multiple organ system failure. Crit Care Med 1990; 18: 822–826, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Henter J I, Arico M, Egeler R M. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 1997; 28: 342–347, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Harvey B, Hickman C, Hinson G, Ralph T, Mayer A. Severe lactic acidosis complicating metformin overdose successfully treated with high-volume venovenous hemofiltration and aggressive alkalinization. Pediatr Crit Care Med 2005; 6: 598–601, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Ronco C, Tetta C, Mariano F. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003; 27: 792–801, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Di Carlo J V, Alexander S R. Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis. Int J Artif Organs 2005; 28: 777–786, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• FDA Updated Public Health Notification: Gambro Prisma. ^® Continuous Renal Replacement System, ] Administration USFaD DOI[CSA]
   Google Scholar
• Elhanan N, Skippen P, Nuthall G, Krahn G, Seear M. Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol 2004; 19: 208–212, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Ronco C, Belomo R, Homel P. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Edtna Erca J 2002; 2(Suppl)7–12, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bouman C S, Oudemans-Van Straaten H M, Tijssen J G, Zandstra D F, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002; 30: 2205–2211, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Med 2001; 27: 978–986, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Honore P M, Jamez J, Wauthier M. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28: 3581–3587, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Keller F, Bohler J, Czock D, Zellner D, Mertz A K. Individualized drug dosage in patients treated with continuous hemofiltration. Kidney Int Suppl 1999; 72: S29–S31, [INFOTRIEVE], [CSA]
   Google Scholar
• Munar M Y, Doyle I C, Meyer M M. Cyclosporine and vancomycin disposition during continuous venovenous hemodiafiltration. Ann Pharmacother 1995; 29: 374–377, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar